Ozempic Maker Novo Nordisk to Cut 9,000 Jobs
The Danish drugmaker said it needed to streamline operations and [...]
Where U.S. Medicines Are Made and How Trump’s Tariffs Could Affect Them
President Trump’s planned pharmaceutical tariffs threaten to hit many of [...]
Novo Nordisk, Ozempic Drugmaker, Sees Stock Plunge 20% After Profit Warning
Novo Nordisk slashed its financial forecasts as it struggled to [...]
Novo Nordisk to Replace C.E.O. After Losing Edge in Weight-Loss Drugs
The Danish drugmaker, which makes Ozempic and Wegovy, has seen [...]
Why Patients Are Being Forced to Switch to a 2nd-Choice Obesity Drug
CVS Caremark decided to stop offering Zepbound in favor of [...]
What to Know About Eli Lilly’s Daily Pill for Weight Loss
Eli Lilly reported promising results from a study of its [...]
Patients Cut Off From Cheaper Obesity Drugs as FDA Halts Sales of Copycats
U.S. regulators are trying to shut down the industry for [...]
Weight Loss Drug Will Be Offered for $499 a Month for Some Patients
Some commercially insured patients stand to save $150 per month [...]
Novo Nordisk Annual Sales Jump on Demand for Ozempic and Wegovy
The Danish maker of Ozempic and Wegovy reported a 25 [...]
Medicare to Negotiate Lower Prices for Weight-Loss Drugs
The government is expected to pay lower prices for Ozempic [...]